Avenue Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Robert Davidow(2.9%)
Avenue Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Fortress Biotech, Inc.(8.0%)
Avenue Therapeutics | 4:持股变动声明-股东 Fortress Biotech, Inc.
Avenue Therapeutics | 4:持股变动声明-股东 Fortress Biotech, Inc.
Avenue Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)
Avenue Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Robert Davidow(9.89%)
Avenue Therapeutics | 4:持股变动声明-股东 Davidow Robert L
Avenue Therapeutics | SC 13G:超过5%持股股东披露文件-Robert Davidow(14.5%)
Avenue Therapeutics | 3:首次持股声明-股东 Davidow Robert L
Avenue Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Fortress Biotech, Inc.(12.1%)
Avenue Therapeutics | 4:持股变动声明-董事 ROSENWALD LINDSAY A MD
Avenue Therapeutics | 4:持股变动声明-股东 Fortress Biotech, Inc.
Avenue Therapeutics | 4:持股变动声明-董事 Charles Faith L.
Avenue Therapeutics | 4:持股变动声明-高管 Jin David
Avenue Therapeutics | 4:持股变动声明-董事 ROSENWALD LINDSAY A MD
Avenue Therapeutics | 4:持股变动声明-董事 KRANZLER JAY D
Avenue Therapeutics | 4:持股变动声明-董事 Oltmans Curtis Gale
Avenue Therapeutics | 4:持股变动声明-董事 Herskowitz Neil
Avenue Therapeutics | 4:持股变动声明-首席执行官 MacLean Alexandra
Avenue Therapeutics | 4:持股变动声明-股东 Fortress Biotech, Inc.
暂无数据